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Background: While many studies have examined differences between body mass index (BMI) categories in terms
of mortality risk and health-related quality of life (HRQL), little is known about the effect of body weight on health
expectancy. We examined life expectancy (LE), health-adjusted life expectancy (HALE), and proportion of LE spent in
nonoptimal (or poor) health by BMI category for the Canadian adult population (age ≥ 20).
Methods: Respondents to the National Population Health Survey (NPHS) were followed for mortality outcomes
from 1994 to 2009. Our study population at baseline (n=12,478) was 20 to 100 years old with an average age of 47.
LE was produced by building abridged life tables by sex and BMI category using data from the NPHS and the
Canadian Chronic Disease Surveillance System. HALE was estimated using the Health Utilities Index from the
Canadian Community Health Survey as a measure of HRQL. The contribution of HRQL to loss of healthy life years
for each BMI category was also assessed using two methods: by calculating differences between LE and HALE
proportional to LE and by using a decomposition technique to separate out mortality and HRQL contributions to
loss of HALE.
Results: At age 20, for both sexes, LE is significantly lower in the underweight and obesity class 2+ categories, but
significantly higher in the overweight category when compared to normal weight (obesity class 1 was
nonsignificant). HALE at age 20 follows these same associations and is significantly lower for class 1 obesity in
women. Proportion of life spent in nonoptimal health and decomposition of HALE demonstrate progressively
higher losses of healthy life associated with lowered HRQL for BMI categories in excess of normal weight.
Conclusions: Although being in the overweight category for adults may be associated with a gain in life
expectancy as compared to normal weight adults, overweight individuals also experience a higher proportion of
these years of life in poorer health. Due to the descriptive nature of this study, further research is needed to explore
the causal mechanisms which explain these results, including the important differences we observed between
sexes and within obesity subcategories.
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As rates of overweight and obesity continue to climb in
Canada and many other developed countries, curbing
and reducing these rates has become a long-term goal
for public health practitioners in these countries [1].
Underweight adults are also at risk for negative health
consequences including elevated mortality [2]. One ap-
proach that can aid in the evaluation of a population’s
health according to body weight category is the estima-
tion of health expectancy by body mass index (BMI).
Health expectancy measures such as health-adjusted life
expectancy (HALE) combine life expectancy (LE) with a
measure of health-related quality of life (HRQL) or dis-
ability to create an indicator for assessing the combined
effects of health and mortality, which is expressed in an
intuitive measure similar to that of life expectancy [3].
Furthermore, in populations where life expectancy is in-
creasing, health expectancies can be used to monitor
whether the proportion of life spent in health is increas-
ing (compression of morbidity) or decreasing (expansion
of morbidity) due to a particular health problem such as
insufficient or excess body weight [4].
Certain associations have been demonstrated between
the body weight categories of underweight, overweight,
and obese (including its two subcategories: moderately
obese and severely obese) and premature mortality. Re-
cent national population-based studies in Canada and
the United States [2,5,6] have demonstrated that being
in the underweight or severely obese BMI category is as-
sociated with an increased risk of mortality amongst
adults in the general population when compared to their
peers in the normal weight BMI category (18.5 ≤ BMI <
25 kg/m2). These same studies also demonstrated a de-
creased risk of mortality for those in the overweight cat-
egory when compared to those in the normal weight
category: a result which was supported by a recent
meta-analysis of all-cause mortality for overweight and
obesity relative to normal weight, which included 97
studies with a combined sample size of more than 2.88
million individuals and more than 270,000 deaths [7].
Other studies have demonstrated an increased risk of
mortality with overweight and lower levels of obesity.
However, these studies tended to be based either on
more restricted populations that exclude older adults, as
well as certain socio-economic status and ethnic groups
which may have a greater number of competing mortal-
ity risks as compared to the general population [8-10].
Additionally, some of these study populations consist
of less-recent cohorts [11,12] where follow-up occurred
during time periods when mortality risk for excess weight
may have been greater [6].
When the effects of BMI on health-related quality of
life are observed, the literature for population-level stud-
ies [13-15] generally demonstrate that for women, thereis a consistent decrease in HRQL across excess weight
categories. For men, overweight and moderate obesity
were associated with higher HRQL in one study [14],
while another study [15] reported an optimal HRQL for
men with a BMI of 26 as opposed to a BMI of 24.5 for
women. A study of HRQL by BMI category in US adults
found that three of six commonly-used HRQL indices
produced significantly lower HRQL results for obese
men as compared to normal weight men [13]. The two
studies [14,15] which addressed underweight demon-
strated that this weight category is associated with lower
HRQL in both sexes, although this association appears
to be age-dependent for women [14].
While these studies provide insight into health losses
due to premature mortality and reduced HRQL, there are
a limited number of studies that examine how BMI im-
pacts on both of these two measures in the form of health
expectancy. Four studies have examined health expectancy
for multiple BMI categories [16-19]. When stratified by
sex, the estimates for health expectancy in these studies
range from small gains for overweight women and negli-
gible losses for men in the excess weight categories, to con-
siderable loss of health expectancy for overweight women
and obese men and women. Several of these studies have
one or more limitations which make it difficult to assess
health expectancy results by BMI category at the popula-
tion level. Two of these studies [17,18] restricted their
study populations to a subgroup of those 55 years and
older, as well as to white Americans and a single city in the
Netherlands, respectively. Another of these studies [19]
based its relative risks for obesity-related morbidity and
mortality on studies using populations other than the study
population, which may lead to biased estimates [20]. In
addition, none of these studies presented complete health
expectancy results by obesity subgroup (i.e., moderate and
severe obesity), despite the important variations in mortal-
ity risk and loss of HRQL observed in these subcategories
in previous studies. Health expectancy for those in the
underweight category has also not been explored to date.
The objective of this study was to address the above-
mentioned gaps by exploring differences in LE and HALE
for each of the World Health Organization BMI categor-
ies, including two obesity subclasses (class 1 and class 2+),
using a representative sample of the Canadian adult popu-
lation aged 20 years and older. We also assessed the spe-
cific contribution of HRQL to losses in HALE by using
two measures: the difference between LE and HALE pro-
portional to LE and the decomposition of HALE into each
of its mortality and HRQL components.
Methods
Data sources
We used National Population Health Survey (NPHS) data
for estimation of mortality attributable to body weight
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for BMI prevalence and HRQL estimation, and Canadian
Chronic Disease Surveillance System (CCDSS) data to es-
timate total mortality rates. The study was limited to the
adult (20 years old and over) Canadian population.
Both NPHS and CCHS are conducted by Statistics
Canada and are designed to collect information on the
health and the determinants of health of the Canadian
population. In both surveys, the samples are weighted
to be representative of the Canadian population. NPHS
is a longitudinal survey while the CCHS is cross-
sectional. The methodology of these surveys has been
described in detail elsewhere [21,22] and are briefly
summarized here.
The first cycle of the NPHS data collection took place
in 1994/1995 and follow-up with this cohort continued
every second year thereafter until the ninth and final
cycle in 2010/2011. We used eight cycles of the data
covering the period from 1994 to 2009. The target popu-
lation of the NPHS household component includes
household residents of all ages in the 10 Canadian prov-
inces in 1994/1995 excluding persons living on Indian
reserves and Crown lands, residents of health institu-
tions, full-time members of the Canadian Forces living
on Canadian Forces bases, and residents of some remote
areas in Ontario and Quebec. The initial sample size was
20,095, and the initial response rate was 86% which lead
to 17,276 respondents, of whom 15,805 agreed to share
their information with Health Canada and the Public
Health Agency of Canada. Mortality follow-up occurred
regardless of response status, and thus there is little loss
to follow-up with mortality as the studied end point.
The survey includes self-reported height and weight as
well as information about health status and health deter-
minants. Eight cycles, or 14 years of follow-up, were
used in this study to estimate the mortality Hazard Ratio
(HR) according to BMI category at baseline. The study
population included 12,478 participants 20 years old and
over. Participants with missing BMI information at
baseline (n = 571) were also excluded, leading to a
sample size of 11,907 for the present study with an age
range of 20 to 100 years old and an average age of 47 in
1994/1995.
The CCHS is a nationally representative sample of
Canadians 12 years of age and over dwelling in house-
holds, with the same exclusions of participants as those
found in the NPHS. Data are available from 2000 and,
since 2007, are collected on an ongoing basis. Prior to
2007, data collection occurred every two years over a
12-month period. In order to reduce the variability in
our estimates, we combined the first three CCHS cycles,
which span the years 2000–2005. The sample size gener-
ated by combining these three cycles for BMI prevalence
estimation was 317,996, with an age range of 20 to 104.The household-level response rate was between 84.9%
and 91.4%, and the individual-level response rate was
between 91.9% and 92.9% during this period. Two dif-
ferent methods are recommended for combining data
from different survey cycles: the separate approach
and the pooled approach [23]. The choice of ap-
proach is based, amongst other things, on the degree
to which the parameter being measured remains con-
stant between cycles. The age-sex-specific BMI preva-
lences were estimated based on the separate approach,
in which a simple average of estimates from each CCHS
cycle being combined is calculated. Since the age-sex-
specific Health Utilities Index (HRQL measure ex-
plained in more detail below) estimates were more
stable across cycles, the pooled approach was used in
which the microdata from each cycle are combined
into a single sample.
The CCDSS is a national collaborative network of
provincial and territorial chronic disease surveillance
systems that collect administrative health care data
[24]. The CCDSS data include death and population
counts by sex and five-year age groups and health in-
formation such as the prevalence and incidence of se-
lected chronic diseases. The CCDSS represents almost
the entire Canadian population, excluding full-time
members of the Canadian Forces, the Royal Canadian
Mounted Police, and individuals in federal correc-
tional facilities. Total mortality rates were estimated
from CCDSS data for the period of 2000–2005 by sex
and five-year age groups. Ethical approval was not re-
quired as this study was based on analysis of second-
ary data and no experimental research on humans
was carried out.
Indicators
Self-reported weight and height were used to calculate
BMI in the NPHS and CCHS by sex and age group.
BMI categories were defined in the study as under-
weight (BMI < 18.5 kg/m2), normal weight (18.5 ≤ BMI <
25 kg/m2), overweight (25 ≤ BMI < 30 kg/m2), obese
class 1 (30 ≤ BMI < 35 kg/m2), and obese class 2+ (BMI ≥
35 kg/m2). A sensitivity analysis was performed to evalu-
ate the impact of using self-reported BMI as compared to
BMI corrected for self-report bias [25].
The measure of HRQL used in the present study was
the Health Utilities Index (HUI) Mark 3 [26], which has
been used in previous studies to calculate HALE [27].
HUI is a preference-based measure that defines health
states according to eight attributes (vision, hearing,
speech, ambulation, dexterity, emotion, cognition, and
pain), with five or six levels ranging from normal to se-
verely limited functioning for each. Single attribute util-
ity scores range from 0.0 (lowest level of functioning) to
1.0 (full functional capacity). The eight attributes are
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utility function:
u ¼ 1:371  b1  b2  b3  b4  b5  b6  b7  b8ð Þ−0:371;
ð1Þ
where u is HUI and bi represents the i-th attribute utility
score [28].
The overall scores on the HUI range from −0.36 (the
worst possible HUI health state) through 0.0 (death) to
1.0 (perfect health). From a societal perspective, some
health states are considered worse than death, and con-
sequently are assigned negative scores. Details are de-
scribed elsewhere [28] on how the utility scores are
derived from preference scores for individual attributes.
Differences of 0.03 or more in overall HUI scores and
0.05 or more in single-attribute utility scores are consid-
ered to be clinically important [26]. CCHS data from
combined cycles were used to estimate HUI by age
group, sex, and BMI category.
Calculating mortality
The relative risk of dying was approximated using the
estimated hazard ratios (HR) for underweight, over-
weight, obese class 1, and obese class 2+ BMI categories
as compared to the normal weight category. Data from
the NPHS provided BMI and age values at baseline as
well as mortality during follow-up. A discrete-time pro-
portional hazard model using a complementary log-log
function (clog-log) was used to estimate HR. The model
was adjusted by BMI category, sex, and age group. The
data were categorized into two age groups (20–64
and ≥65) with the assumption that the risk was con-
stant within each group. The linearity assumption was
supported and goodness of fit was confirmed using
the Hosmer-Lemeshow test.
By taking into account BMI prevalence by sex and
five-year age group and the relative risk of dying for each
BMI category relative to the normal weight category by
sex and for two age groups, the age-specific mortality
rates for the total Canadian population were partitioned
into mortality rates by BMI class, sex, and five-year age
group. The formulae used to determine mortality rates
are available in an Additional file 1 to this article.
Calculation of LE and HALE
The Chiang method [29] was used to generate period
(2000–2005) life tables by BMI categories and sex
using 14 standard age groups (20–24.9, 25–29.9 …,
80–84.9, ≥85 years). Closure of life tables was done
by fitting a Gompertz function to the last open-ended ≥85
age interval, as described by Hsieh [30]. The Sullivan
method [31] was applied for the HALE calculation. This
method has been demonstrated to be an unbiased andconsistent estimator of health expectancy [32]. According
to this method the “life-years lived” were adjusted by the
HUI.
L′x ¼ Lx  HUIx ð2Þ
Where L′x are adjusted life-years lived in age-interval x,
Lx are life-years lived in age-interval x, and HUIx is Health
Utilities Index Mark 3 for people in age-interval x.
The variance and 95% confidence intervals for LE and
HALE were estimated using the bootstrap methodology
[33]. The bootstrapping approach we used involves
applying the bootstrap weights calculated by Statistics
Canada through a resampling of the NPHS and CCHS
surveys. These account for the complex survey designs
by producing new sets of survey weights with each iter-
ation. 250,000 HR, BMI prevalence, and HUI combina-
tions were generated, with each combination leading to
a set of HALE by BMI results. Z-tests were used to test
the statistical significance of the differences in LE and
HALE between BMI categories.
In order to assess the proportion of life expectancy
spent in a less-than-optimal (or poor) state of health (P),




Subanalysis of mortality and HRQL components
The Nusselder decomposition (i.e., partitioning) method
[34] was applied to quantify the difference in HALE at-
tributable to differences in premature mortality and dif-
ferences in loss of HRQL between BMI categories. This
technique is based on the Sullivan method and is an
extension of the decomposition method for life ex-
pectancy developed by Arriaga [35]. For each age group,
the change in HALE between the comparison groups
(ΔHALE = Lx1HUI1 – Lx2HUI2, where Lx2 refers to the
number of years lived by the persons in the normal weight
reference category for age interval x and Lx1 refers to the
number of years lived by the persons in the comparison
BMI category for age interval x) is partitioned into the fol-
lowing components:
ΔHALE ¼ ΔMORBþ ΔMORT
¼ LX1þLX2
2
ΔHUI þ HUI1 þ HUI2
2
ΔLX ð4Þ
The first component (ΔMORB) estimates changes
due to HRQL and the second one (ΔMORT) esti-
mates changes due to mortality. The age specific compo-
nents are then summed to give the HRQL and mortality
decomposition.
All calculations and statistical analyses were conducted
using SAS version 9.2.
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BMI prevalence and HRQL by BMI category
Age-sex-specific BMI category prevalences and HUI
scores by BMI category are shown in Table 1. Normal
weight is the most prevalent category for women in all
age categories studied, whereas for men, this was only
the case for those 20–34 years old and 75 years and
older: overweight was the most prevalent category forTable 1 BMI prevalence by category and HRQL by BMI catego














20-24 9.9 67.9 14.8 5.1 2.3
25-29 6.9 61.9 19.4 7.6 4.2
30-34 4.4 59.3 23.0 8.9 4.4
35-39 4.2 59.1 23.1 9.0 4.6
40-44 3.4 57.3 25.2 9.5 4.6
45-49 2.5 53.7 28.2 10.3 5.4
50-54 1.9 46.9 32.4 13.1 5.8
55-59 1.7 43.5 34.9 13.7 6.2
60-64 2.0 42.2 35.8 14.4 5.6
65-69 2.4 43.0 36.6 13.1 4.9
70-74 3.2 43.4 34.9 13.7 4.8
75-79 4.3 46.7 34.4 11.5 3.2
80-84 5.9 51.1 31.1 9.7 2.2
≥85 9.2 56.9 25.5 6.8 1.6














20-24 2.6 60.4 27.9 6.5 2.6
25-29 1.6 49.1 35.0 10.8 3.5
30-34 0.9 42.3 40.1 13.1 3.6
35-39 0.8 39.3 43.3 12.9 3.7
40-44 0.8 38.1 44.5 13.1 3.5
45-49 0.6 36.5 44.1 14.7 4.2
50-54 0.5 34.2 44.9 15.5 4.8
55-59 0.5 33.0 45.4 16.5 4.6
60-64 0.8 34.1 45.5 15.6 4.0
65-69 0.9 35.8 44.8 14.7 3.8
70-74 1.1 38.8 45.6 11.8 2.7
75-79 1.5 43.4 43.3 10.1 1.7
80-84 2.8 49.7 38.1 7.9 1.5
≥85 2.5 58.6 32.8 5.5 0.5
All ages (≥20) 1.1 41.1 41.4 12.8 3.6
Source of data: Canadian Community Health Survey, combined cycles 2000–2001, 2
*p < 0.05: statistically significant difference vs. normal weight (significance tests formen in the other age groups. The prevalences of under-
weight and obesity class 2+ are relatively low in com-
parison to the other BMI groups. For HUI in women,
normal weight is generally associated with the highest
HRQL, followed closely by overweight, underweight,
obesity class 1, and obesity class 2+. HUI scores for
women ≥20 years old are significantly lower for all BMI
categories when compared to women in the normalry, sex, and age group, Canada, 2000-2005











0.88 0.92 0.90 0.88 0.81
0.92 0.92 0.90 0.89 0.90
0.89 0.91 0.89 0.88 0.81
0.92 0.91 0.91 0.87 0.83
0.86 0.90 0.88 0.86 0.80
0.85 0.89 0.86 0.83 0.80
0.79 0.88 0.86 0.84 0.74
0.82 0.88 0.87 0.79 0.76
0.80 0.88 0.84 0.81 0.74
0.84 0.87 0.86 0.81 0.69
0.76 0.84 0.83 0.77 0.62
0.75 0.79 0.78 0.69 0.55
0.62 0.74 0.69 0.61 0.63
0.55 0.60 0.64 0.54 0.36











0.84 0.91 0.92 0.89 0.86
0.82 0.92 0.92 0.91 0.88
0.86 0.92 0.93 0.91 0.87
0.81 0.90 0.91 0.92 0.84
0.83 0.90 0.91 0.91 0.86
0.70 0.89 0.90 0.91 0.84
0.73 0.87 0.89 0.88 0.84
0.72 0.89 0.87 0.86 0.81
0.81 0.86 0.87 0.85 0.76
0.74 0.88 0.86 0.83 0.76
0.74 0.86 0.85 0.79 0.78
0.73 0.80 0.79 0.81 0.75
0.54 0.74 0.73 0.72 0.55
0.52 0.64 0.61 0.48 0.57
0.79* 0.89 0.89 0.88* 0.83*
003, and 2005, Statistics Canada.
HUI score, all ages, by sex only).
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normal weight are associated with the highest HRQL.
Obesity class 1 is associated with a lower level of
HRQL, although values converge with those of over-
weight and normal weight men in middle age (40–55 years
old). Obesity class 2+ men have the second lowest
level of HRQL, with underweight men having the
lowest. Men ≥20 years old in the underweight cat-
egory and in both obesity subclasses have significantly
lower HUI scores (p < 0.05).
During the 14-year follow-up period, 2113 deaths were
observed in our study population. We observe a signifi-
cantly increased risk of mortality among the under-
weight (age-sex-adjusted HR 1.49, 95% CI: 1.17, 1.90)
and obesity class 2+ (age-sex-adjusted HR 1.42, 95% CI:
1.16, 1.72) categories, as compared to the normal weight
category. We observe a significantly reduced risk of
mortality among the overweight (age-sex-adjusted HR
0.69, 95% CI: 0.62, 0.78) and obesity class 1 (age-sex-
adjusted HR 0.84, 95% CI: 0.72, 0.98) categories, as com-
pared to the normal weight category. When HRs are
stratified by age group (20–64 and ≥65 years old, results
not shown), significantly elevated risks for mortality are
observed for underweight individuals 65 years of age or
older, as well as for those aged 20 to 64 years old in the
obesity class 2+ category (p < 0.05). Risk for mortality is
significantly decreased for those 65 years or older in the
overweight and obesity class 1 categories (p < 0.05). The
direction of the mortality risk association is the sameTable 2 Life Expectancy (LE), Health-Adjusted Life Expectancy




(95% CI) (56.3, 61.6) (62.6, 63.0)
HALE 48.5* 54.1
(95% CI) (46.7, 50.6) (53.8, 54.4)
LE – HALE 10.2 8.7




(95% CI) (50.3, 56.1) (56.8, 57.6)
HALE 41.0* 50.0
(95% CI) (38.3, 43.6) (49.6, 50.4)
LE – HALE 12.0 7.2
[LE - HALE]/LE 0.226 0.126
95% confidence intervals based on bootstrapping results.
*p < 0.01: statistically significant difference vs. normal weight (significance tests on f
Sources of data: National Population Health Survey, Cycles 1–8 (1994/1995-2009), S
2000–2001, 2003, and 2005, Statistics Canada; Canadian Chronic Disease Surveillancbetween age groups for each BMI category with the ex-
ception of underweight. The sensitivity analysis per-
formed to evaluate the impact of using self-reported
BMI compared to BMI corrected for self-report bias
(results not shown) demonstrates that HRs recalculated
using the corrected BMI only marginally change the esti-
mates of mortality risk by BMI category. However, the
obesity class 1 HR is no longer statistically significant at
the p < 0.05 threshold when the correction factor is
implemented.
Life expectancy at 20 years of age is lowest for Canadian
men and women in the underweight and obesity class 2+
categories, whereas the highest LE at this age is found for
those in the overweight, obesity class 1, and normal
weight categories (Table 2).
Health-adjusted life expectancy at 20 years of age for
Canadian women is lowest in the obesity class 2+ cat-
egory, followed by those in the underweight and obesity
class 1 categories. Women at this age in the overweight
category have the highest HALE, followed by normal
weight. For 20-year-old men, those in the underweight
and obesity class 2+ categories have the lowest HALE
estimates, while those classified as overweight exhibit
the highest estimates, followed by obesity class 1 and
normal weight.
Results for the difference between LE and HALE for
Canadians at age 20 (last two rows of Table 2) show the
average cumulative amount of time spent in less than
optimal health both in terms of absolute number of(HALE), and differences in LE and HALE at age 20 by BMI
les
Overweight Obesity class 1 Obesity class 2+
66.5* 64.6 59.3*
(65.5, 67.5) (63.0, 66.2) (56.9, 61.3)
55.6* 51.4* 44.1*




Overweight Obesity class 1 Obesity class 2+
61.0* 59.1 53.5*
(60.2, 61.9) (57.5, 60.6) (51.1, 55.6)
52.9* 50.4 43.8*
(52.2, 53.7) (49.2, 51.6) (42.0, 45.6)
8.1 8.7 9.7
0.133 0.147 0.181
irst two lines for each sex only).
tatistics Canada; Canadian Community Health Survey, combined cycles
e System, 2000–2005, Public Health Agency of Canada.
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Differences in LE and HALE for women range from
8.7 years for normal weight up to a high of 15.2 years
for women in the obesity class 2+ category. Meanwhile,
underweight women spend a greater amount of time in
nonoptimal health than normal weight women but spend
a lesser amount of time in this state than women in the
excess weight categories. Similar trends for women in each
BMI category are observed when we examine life spent in
less than optimal health as a proportion of life expectancy
(represented as (LE-HALE)/LE), the sole exception being
underweight women, who have a greater proportion of LE
spent in nonoptimal health than do overweight women.
When compared to women, men have smaller differences
in life years spent in nonoptimal health between the nor-
mal and excess weight categories: from 7.2 years in normal
weight to 9.7 years in obesity class 2+. Among men, those
in the underweight category have the highest absolute
number of years spent in poor health with 12.0 years.
These trends persist for men when calculated as a propor-
tion of LE.
When the proportion of LE spent in nonoptimal health
is examined by age group (Figures 1 and 2), we see that
the differences between BMI categories observed in
Canadian women at age 20 remain largely the same
across age groups. Obese and underweight women at
all ages demonstrate higher proportions of life spent in
nonoptimal health compared to normal weight women,
while this proportion is also higher amongst overweight
women up to the age of 75. However, for men there
are some notable differences in the older age groups.20 25 30 35 40 45
Underweight 0.174 0.178 0.188 0.197 0.213 0.222
Normal weight 0.139 0.143 0.149 0.156 0.164 0.174
Overweight 0.164 0.169 0.175 0.180 0.190 0.198
Obese 1 0.204 0.211 0.221 0.230 0.240 0.254


















Figure 1 Proportion of life expectancy spent in nonoptimal health by
Population Health Survey, Cycles 1–8 (1994/1995-2009), Statistics Canada; C
and 2005, Statistics Canada; Canadian Chronic Disease Surveillance System,Although the general pattern persists (higher proportion
of LE spent in nonoptimal health amongst men of excess
weight and especially underweight men when compared
to normal weight), there is an increasingly greater propor-
tion of LE spent in nonoptimal health for men in the
obesity class 1 category as age increases: from a propor-
tion that is 1.17 times higher than normal weight men at
age 20 to 1.32 times higher at age 60 and 1.44 times higher
at age 85 and older.
When the differences in HALE at age 20 between a
given BMI category and the reference normal weight
category are broken down (i.e., decomposed) into their
HRQL and mortality components (Table 3) for females,
there is a progressive loss of HALE due to loss of HRQL
as BMI increases beyond normal weight, ranging from a
loss of one year in health expectancy in overweight to a
loss of almost eight years for women in obese class 2+.
In contrast, the contribution of mortality to HALE losses
is not seen until obese class 2. When decomposing
HALE differences for males at age 20, we see much
smaller losses in health expectancy due to HRQL losses
(from almost no loss in HALE in overweight to a loss of
3.5 years in obese class 2+), though the same general
mortality trends are similar to those of females. Gains in
HALE for overweight men and women are entirely
accounted for by the contribution of reduced mortality.
For underweight, both sexes show significant, large
losses in HALE and these losses are seen in both mortal-
ity and HRQL components. Underweight males, how-
ever, appear to experience a greater burden, which is
seen predominantly in the HRQL component.50 55 60 65 70 75 80 85+
0.236 0.237 0.251 0.267 0.314 0.352 0.413 0.448
0.183 0.195 0.209 0.227 0.256 0.301 0.343 0.408
0.206 0.215 0.231 0.248 0.274 0.308 0.339 0.358
0.265 0.282 0.292 0.315 0.352 0.393 0.438 0.459
0.337 0.352 0.379 0.411 0.448 0.477 0.506 0.633
Age group (years)
age group, females, Canada, 2000–2005. Sources of data: National
anadian Community Health Survey, combined cycles 2000–2001, 2003,
2000–2005, Public Health Agency of Canada.
20 25 30 35 40 45 50 55 60 65 70 75 80 85+
Underweight 0.226 0.232 0.239 0.249 0.259 0.276 0.269 0.270 0.272 0.299 0.321 0.363 0.466 0.488
Normal weight 0.126 0.128 0.134 0.142 0.144 0.155 0.159 0.167 0.176 0.193 0.220 0.265 0.303 0.364
Overweight 0.133 0.139 0.144 0.151 0.158 0.168 0.179 0.190 0.203 0.221 0.247 0.288 0.333 0.394
Obese 1 0.147 0.151 0.156 0.164 0.175 0.188 0.203 0.215 0.233 0.256 0.285 0.313 0.400 0.524



















Figure 2 Proportion of life expectancy in nonoptimal health by age group, males, Canada, 2000–2005. Sources of data: National
Population Health Survey, Cycles 1–8 (1994/1995-2009), Statistics Canada; Canadian Community Health Survey, combined cycles 2000–2001, 2003,
and 2005, Statistics Canada; Canadian Chronic Disease Surveillance System, 2000–2005, Public Health Agency of Canada.
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This study estimated life expectancy and health adjusted
life expectancy by BMI category for Canadian men and
women, age 20 and over, during the period 2000–2005.
Our findings indicate that there are important health ex-
pectancy differences between BMI categories, as well as
between the sexes for those in the lower excess weight
categories. When estimated at 20 years of age, both
sexes have significant losses of LE and HALE in the
underweight and higher obesity classes and significant
gains in LE and HALE in the overweight category when
compared to those in the normal weight category.
Women and men at 20 also demonstrate progressively
higher proportions of life spent in nonoptimal health inTable 3 Contribution of Mortality and HRQL components to d














-5.6* REF 1.5* -2.7* -
Difference due to
premature mortality
-2.8 REF 2.6 1.2 -
Difference due to
loss of HRQL
-2.7 REF -1.0 -3.8 -
Based on decomposition technique developed by Nusselder and Looman (2004) an
HALE (i) = HALE for indicated BMI category; HALE(n) = HALE for normal BMI categor
*p < 0.01 HALE difference: statistically significant difference vs. normal weight (signi
aSome discrepancies in HALE difference and component difference are due to roun
Sources of data: National Population Health Survey, Cycles 1–8 (1994/1995-2009), S
2000–2001, 2003, and 2005, Statistics Canada; Canadian Chronic Disease Surveillancexcess weight categories as compared to those of normal
weight.
Women and men in the obese class 1 category do not
share the same HALE experience at 20: the former have
a significantly lower HALE while there is no effect for
the latter. Furthermore, men in the obese class 1 cat-
egory saw progressive increases in the proportion of life
spent in nonoptimal health with each successive age
group that were more substantial than those of normal
weight men, while women in this BMI category experi-
enced increases proportional to normal weight women
in all age groups. Finally, although overweight men and
women both had significantly higher HALE at age 20,















10.0* -9.0* REF 2.9* 0.4 -6.2*
2.2 -3.0 REF 2.9 1.3 -2.7
7.8 -5.9 REF 0.0 -1.0 -3.5
d Arriaga et al. (1984).
y (reference).
ficance tests on first line only).
ding.
tatistics Canada; Canadian Community Health Survey, combined cycles
e System, 2000–2005, Public Health Agency of Canada.
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to normal weight women, whereas this increase was
relatively small when comparing normal weight and
overweight men.
This study adds to the current literature on life expect-
ancy and health expectancy by BMI category by using
available datasets to estimate age-sex-specific mortality
and HRQL by BMI category in Canada. When our re-
sults are compared to those of the only other study that
examined health expectancy by BMI category using a
representative sample of populations at the country level
[16], we found similar patterns in life expectancy and
proportion of life spent in nonoptimal health (measured
as LwD/LE in this other study, where LwD is Life with
Disability) amongst normal weight, overweight, and
obese men and women. Ours is the first study to our
knowledge to report on health expectancy for the obesity
subcategories and for the underweight category. When
the WHO BMI category for obesity was broken down
into subclasses, we observed important variations in
HALE by sex. Majer et al. [16] estimated the hazard
rates of various disability states by obesity subcategory
in a sensitivity analysis and also found heterogeneity in
this weight category: those in the obese class 2+ category
were significantly less likely to recover from disability
compared to participants of normal weight, while those
in the obese class 1 category demonstrated no significant
difference for recovery. Other population-based studies
examining mortality risk and years of life lost by obesity
subcategory [2,5,6,36] demonstrate a similar trend of
modest to negative risk for premature mortality in the
lower obesity class coupled with more significant risks in
the higher classes. This trend has also been observed for
men with respect to loss of HRQL, although women
tend to have a more important loss of HRQL as BMI in-
creases [14]. With respect to underweight individuals,
the observed results are consistent with what was ex-
pected based on the evidence regarding both mortality
and HRQL among this group. Underweight may be as-
sociated with malnutrition, sarcopenia, low-grade in-
flammation, and frailty, which are each associated with
mortality risk and decreased quality of life [37].
The results we observed for LE by BMI category ap-
pear to support those found in the recent meta-analysis
of all-cause mortality for overweight and obesity relative
to normal weight in the general population [7]. This
meta-analysis and individual studies with similar results
have generated much discussion about the so-called
“obesity paradox” where lower mortality risk is associ-
ated with those in the overweight BMI category and
where there is no difference in mortality risk associated
with the obesity class 1 category compared to those in
the normal weight category. Some of the potential rea-
sons proposed for these seemingly counterintuitiveresults are addressed in the limitations section below:
imperfect nature of BMI as a predictor of metabolic risk;
BMI being measured solely at baseline and thus not ac-
counting for the effect of body weight changes over
time; confounding due to pre-existing illness at baseline;
use of self-reported height and weight; and issues around
proper control for tobacco use and other potentially
modifying factors in the analysis. Other issues of import-
ance not addressed here include: heterogeneity of mortal-
ity risk in the BMI normal weight category (i.e., those with
a BMI between 18.5 and 22 have been shown to have
higher mortality risk); better management of risk factors
in overweight and obese clients by the health care com-
munity; and the possible benefit of having some adipose
reserve during periods of acute catabolic illness [38].
In the absence of a sufficiently large dataset with a
measure of BMI and mortality follow-up, our approach
of estimating Canadian HR for BMI mortality and com-
bining this with death data to create age-sex-specific
mortality rates by BMI category represents a feasible
alternative method. However, the hazard ratios used
to produce age-sex-specific BMI mortality are based
on height and weight assessments made among the
Canadian adult household population in 1994/1995. It
is possible that the relationship between BMI and mortal-
ity has changed in subsequent cohorts, which would have
an impact on estimates of LE and HALE. Future research
should be conducted to confirm our results by using na-
tional mortality follow-up of early Canadian Community
Health Survey cycles in order to determine more recent
and stable mortality rates by BMI category.
While our study was based on a representative sample
of the Canadian population, certain subpopulations were
excluded from the NPHS and CCHS, most notably those
in long-term care institutions. It is possible that risks for
mortality and loss of HRQL are greater among those liv-
ing in long-term care institutions and, as such, these in-
dividuals may not have the same LE and HALE profile
as that of the community-dwelling population used in
our study.
We did not assess BMI at multiple intervals during
follow-up, which could lead to misclassification of mor-
tality risk for subjects who transition to and from
higher-risk BMI categories during follow-up. Indeed,
there is evidence to suggest that, among individuals hav-
ing recently experienced a life-threatening event related
to cardiovascular disease (e.g., myocardial infarction or
stroke), those with excess weight display healthier trajec-
tories of lifestyle and weight changes than normal weight
individuals [39]. Although a recent study determined that
repeated measures of BMI did not change mortality esti-
mates [40], future analyses should incorporate more com-
plex analytical methods and life-course conceptual models
to address this potential bias [39].
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existing illness (or what is commonly referred to in the
obesity literature as “reverse causation” or “washout”).
Certain studies have found that by excluding deaths that
occur in the first few years of follow-up, mortality risks
associated with the excess weight BMI categories be-
come much higher. It is hypothesized that this is due to
the greater presence of pre-existing illnesses amongst
those in the normal weight BMI category at baseline,
which in turn lowers their life expectancy compared to
those with an excess body mass [41]. A recent mortality
study using the same cohort as our study found that
results by BMI category were not significantly affected
when deaths occurring within the first four years of
follow-up were excluded from analysis [5]. Furthermore,
studies that actually assess body weight prior to baseline
demonstrate no clear association between pre-existing
weight loss and subsequent development of cancer or
other chronic diseases commonly perceived to be associ-
ated with both weight loss and increased mortality risk.
Methods to address confounding by illness-related weight
loss, such as excluding deaths, may additionally introduce
new biases since they will most likely also be excluding
large numbers of subjects whose weight loss is not related
to illness [42].
We also combined cycles of the CCHS in order to ob-
tain greater stability in estimates of BMI prevalence and
HRQL by BMI category. However, this approach may
obscure possible trends occurring over the time period
covered by the combined cycles.
Self-reports of height and weight, which are used to
calculate HR and to estimate age-sex-BMI category-
specific HRQL estimates, systematically underestimate
true weight and overestimate true height. The results of
this study may not reflect health expectancy estimates
according to BMI calculated using measured height and
weight. In order to assess the extent of this bias, we con-
ducted sensitivity analyses using a previously published
algorithm [25] that adjusts self-reported BMI values so
that they more closely approximate directly-measured
values. While estimates calculated using this correction
factor did not appreciably differ from uncorrected esti-
mates, the HR for obese class 1 went from being mar-
ginally significant at the p < 0.05 threshold to being no
longer significant at that threshold. In addition, the LE
calculated for obese class 1 was higher than that of nor-
mal weight men and women but was not significant at
the p < 0.01 level. This leads us to conclude that the as-
sociation between obese class 1 men and women for de-
creased mortality risk and increased LE is a weak one
and should be interpreted with some caution.
The current study also did not report on health expect-
ancy using other measures of body weight (e.g., waist cir-
cumference, skinfold thickness, waist-to-height ratio), asnone of these alternatives are available in the National
Population Health Survey. These measures can provide
more accurate representations of adiposity, and conse-
quently health risk, by distinguishing between lean and fat
body mass [37,43].
Since the goal of this study was to describe HALE by
BMI at the population level, we did not adjust for any
socioeconomic or behavioral factors. We did however
assess the effect of tobacco smoking on our study re-
sults by introducing a smoking covariate (“ever” versus
“never” tobacco smoker) into the adjusted mortality haz-
ard ratio model. The smoking covariate did not signifi-
cantly change the estimates and was therefore not
included in this report. This finding is consistent with pre-
vious recent research on mortality by BMI category using
NPHS study data [5], although reduced sample size in that
study may have decreased the power to detect effects.
Since our study is based on the same cohort, we may have
experienced the same decrease in power. Majer et al.,
using a much larger sample size (n = 66,331), found that
daily smokers had a lower LE compared to never-smokers
of the same BMI category. However, their study also ob-
served that patterns of life expectancy between each BMI
category did not change appreciably when stratifying by
smoking status [16]. Whether factors such as tobacco
smoking, alcohol consumption, physical activity level, edu-
cation, and income moderate observed levels of HALE by
BMI group could be examined in future studies. It would
also be important to consider that some of these factors
commonly treated as confounders are part of the causal
web surrounding behavior, BMI, and health, and a stra-
tegic approach considering potential mechanisms under-
pinning the observed relationships should take this into
account.
Conclusions
Consistent with other reports in the literature, our study
among Canadian adult males and females found that
those who are overweight or moderately obese have a
higher or equivalent life expectancy respectively than
those who have a normal weight. We also found a pro-
gressive increase of proportion of LE spent in nonopti-
mal health as BMI progresses beyond normal weight in
both sexes for the Canadian adult population. Based on
our results, which demonstrate an increased proportion
of life expectancy spent in nonoptimal health for all
overweight and obese individuals, as well as a loss of life
expectancy for obese class 2+ individuals, our study re-
inforces the public health message which states that
public health interventions should continue to focus on
preventing normal weight and overweight persons from
becoming obese. It should be noted that this study pro-
vides descriptive, summary estimates of the mortality
and morbidity experience of Canadians by BMI category
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the causal relationship between excess and insufficient
body weight on the one hand and life expectancy and
healthy life expectancy on the other. As such, further re-
search is needed to identify which modifying behaviors
and biological factors may be driving these results, in-
cluding some of the differences between the sexes ob-
served in our study. Of particular interest would be an
investigation of the role these factors play in the hetero-
geneity of LE and HALE results in the obesity subcat-
egories (e.g., life expectancy results in both sexes and
health expectancy results in men). Finally, more enquiry
is also needed to better understand the strengths and
limitations of assessing life expectancy and health ex-
pectancy by body weight with currently available mea-
sures, and in particular with the BMI measure.
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